Macrogenics (MGNX) Misses Q2 EPS by 11c, Misses on Revenue

Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.57), $0.11 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $28.06 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Varonis Systems (VRNS) call put ratio 5.1 calls to 1 put with a focus on July 35, 40 and 45 calls as share price up 9%
• SPS Commerce hires Morgan Stanley, explores sale - Reuters